Abstract
The t(14;18)(q32;q21) translocation is closely associated with follicular lymphoma (FL), and is routinely assessed with molecular methods exploring BCL2 breakpoints for both diagnosis and minimal residual disease (MRD) monitoring. We and others have previously reported new recurrent breakpoints (3′BCL2 and 5′mcr) which could be easily analyzed. In this study, we characterized the BCL2 breakpoints in 113 untreated patients with t(14;18)-positive FL and correlated their location with the location of JH break and with the clinical features. Breakpoints were respectively located at the major breakpoint region (MBR) in 73 cases (65%), at the minor cluster region (mcr) in 10 cases (9%), at 3′BCL2 in 14 cases (12%) and at 5′mcr in seven cases (6%). Finally, the breakpoint could not be located in nine patients (8%). 5′mcr cases were associated with bulky and high-stage disease, with frequent extranodal involvement and bone marrow infiltration. Survival studies did not show any correlation between breakpoint location and clinical outcome. The joining JH6 segment was the most frequently involved whatever the breakpoint location. In conclusion, unusual BCL2 breakpoints are found in about 20% of newly diagnosed follicular lymphomas and their study should be considered in the investigation of BCL2-JH rearrangement. It was not possible, in this series, to demonstrate any correlation between breakpoint location and either initial characteristics of the disease or survival of the patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M . Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer N Engl J Med 1987 316: 79–84
Bordeleau L, Berinstein NL . Molecular diagnostics in follicular non-Hodgkin's lymphoma: a review Semin Oncol 2000 27: 42–52
Tsujimoto Y, Cossman J, Jaffe E, Croce CM . Involvement of the bcl-2 gene in human follicular lymphoma Science 1985 228: 1440–1443
Cleary ML, Galili N, Sklar J . Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas J Exp Med 1986 164: 315–320
Ngan BY, Nourse J, Cleary ML . Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas Blood 1989 73: 1759–1762
Hillion J, Mecucci C, Aventin A, Leroux D, Wlodarska I, Van Den Berghe H, Larsen CJ . A variant translocation t(2;18) in follicular lymphoma involves the 5′ end of bcl-2 and Ig kappa light chain gene Oncogene 1991 6: 169–172
Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F, Jardin F, Duval C, Tilly H, Bastard C . Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3′ BCL2 breakpoints and evidence of a new cluster Leukemia 2000 14: 1563–1569
Willis TG, Jadayel DM, Coignet LJ, Abdul-Rauf M, Treleaven JG, Catovsky D, Dyer MJ . Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction Blood 1997 90: 2456–2564
Akasaka T, Akasaka H, Yonetani N, Ohno H, Yamabe H, Fukuhara S, Okuma M . Refinement of the BCL2/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets Genes Chromosomes Cancer 1998 21: 17–29
Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD . Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma Ann Intern Med 1988 108: 14–20
Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A, Monconduit M, Bastard C . Prognostic value of chromosomal abnormalities in follicular lymphoma Blood 1994 84: 1043–1049
Lopez-Guillermo A, Cabanillas F, McDonnell TI, McLaughlin P, Smith T, Pugh W, Hagemeister F, Rodriguez MA, Romaguera JE, Younes A, Sarris AH, Preti HA, Lee MS . Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma Blood 1999 93: 3081–3087
Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, Chott A, Kneba M, Mannhalter C, Nadel B . Follicular lymphomas’ BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation Blood 2000 95: 3520–3529
Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U . Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma Cancer Res 2001 61: 1629–1636
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD . World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997 J Clin Oncol 1999 17: 3835–3849
Tilly H, Bastard C, Delastre T, Duval C, Bizet M, Lenormand B, Dauce JP, Monconduit M, Piguet H . Cytogenetic studies in untreated Hodgkin's disease Blood 1991 77: 1298–1304
Mitelman F (ed). An International System For Human Cytogenetic Nomenclature S Karger: Basel 1995
Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuijs AJ, Jacobs DC, Joosten SA, van Wering ER, van Dongen JJ, van der Schoot CE . Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia Leukemia 2000 14: 1426–1435
Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples Br J Cancer 1977 35: 1–39
Rothman KJ . Estimation of confidence limits for the cumulative probability of survival in life table analysis J Chronic Dis 1978 31: 557–560
Horsman DE, Gascoyne RD, Coupland RW, Coldman AJ, Adomat SA . Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma Am J Clin Pathol 1995 103: 472–478
Yamada M, Wasserman R, Reichard BA, Shane S, Caton AJ, Rovera G . Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes J Exp Med 1991 173: 395–407
Brezinschek HP, Brezinschek RI, Lipsky PE . Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction J Immunol 1995 155: 190–202
Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG . BCL2 oncogene translocation is mediated by a chi-like consensus J Exp Med 1992 175: 1575–1588
Stamatopoulos K, Kosmas C, Belessi C, Stavroyianni N, Kyriazopoulos P, Papadaki T . Molecular insights into the immunopathogenesis of follicular lymphoma Immunol Today 2000 21: 298–305
Acknowledgements
This work was supported by the Comité Départemental de Seine-Maritime de la Ligue Nationale Française Contre le Cancer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buchonnet, G., Jardin, F., Jean, N. et al. Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease?. Leukemia 16, 1852–1856 (2002). https://doi.org/10.1038/sj.leu.2402568
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402568
Keywords
This article is cited by
-
Gastrointestinal follicular lymphoma: review of the literature
Journal of Gastroenterology (2010)